Bayesian Capital Management’s Prospect Capital PSEC Stock Holding History

Bayesian Capital Management’s Portfolio PSEC Stock Details PSEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-51,700	Closed	-$339K	–	690
2018 Q1	$339K	Buy	+51,700	New	+$345K	0.09%	366
2016 Q2	–	Sell	-47,200	Closed	-$343K	–	516
2016 Q1	$343K	Buy	+47,200	New	+$314K	0.32%	114

Other funds holding PSEC

Muzinich & Co New York $286M AUM 21.05% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bayesian Capital Management's PSEC Position: Q2 2018 in Review

Bayesian Capital Management sold out of Prospect Capital (PSEC) in Q2 2018, closing a stake of 51,700 shares — an estimated $339K sold.

Bayesian Capital Management first reported a position in PSEC in Q1 2016 and held it in 2 quarters. The position peaked at $343K in Q1 2016. 216 funds tracked by Wall St. Rank hold PSEC as of Q2 2018.

Bayesian Capital Management reported no remaining Prospect Capital position as of Q2 2018 after selling out during the quarter.
Bayesian Capital Management sold 51,700 Prospect Capital shares in Q2 2018, an estimated $339K.
Bayesian Capital Management first reported a position in Prospect Capital in Q1 2016 and held it in 2 quarters.
Bayesian Capital Management's Prospect Capital position peaked at $343K in Q1 2016.
216 funds tracked by Wall St. Rank held Prospect Capital as of Q2 2018.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.